ArticleOPEN ACCESS

The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders

Molecular Genetics and Metabolism Reports
DOI: 10.1016/j.ymgmr.2021.100812
6Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Considering that some Inherited Metabolic Disorders (IMDs) can be diagnosed in patients with no distinctive clinical features of IMDs, we aimed to evaluate the power of exome sequencing (ES) to diagnose IMDs within a cohort of 547 patients with unspecific developmental disorders (DD). IMDs were diagnosed in 12% of individuals with causative diagnosis (177/547). There are clear benefits of using ES in DD to diagnose IMD, particularly in cases where biochemical studies are unavailable. Synopsis: Exome sequencing and diagnostic rate of Inherited Metabolic Disorders in individuals with developmental disorders.

Author supplied keywords

Cite

CITATION STYLE

APA

Delanne, J., Bruel, A. L., Huet, F., Moutton, S., Nambot, S., Grisval, M., … Thauvin-Robinet, C. (2021, December 1). The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders. Molecular Genetics and Metabolism Reports. Elsevier Inc. https://doi.org/10.1016/j.ymgmr.2021.100812

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free